Podcasts about CGM

Ten pounds in two weeks. No hunger. No craving for coffee or alcohol. This is Jeff's personal, week-by-week account of starting tirzepatide (sold as Zepbound), tracked through blood sugar, cholesterol markers, and a noticeable dimming of everyday motivation and joy. What changed in the first two weeks: appetite, weight, and energy Tracking glucose, LDL, ApoB, and other metabolic markers with a CGM and blood panels Why alcohol and coffee stopped feeling rewarding The emerging link between GLP-1s, dopamine, and the brain's reward circuitry The trade-off between appetite control and a sense of vitality or spark This episode is for anyone weighing GLP-1s for themselves, or curious what the drugs are actually like beyond the headlines. This episode was made possible by: CocoaVia:. Use code COMMUNE2026 for 25% off at CocoaVia.com LMNT: Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at ⁠⁠drinklmnt.com/commune⁠⁠. Stemregen: Get 20% off your first order at stemregen.co/commune with the code COMMUNEPOD Vivobarefoot: Try Vivobarefoot risk-free with a 100-day return guarantee, and get 25% off your order at ⁠⁠vivobarefoot.com/commune⁠⁠. Stripes: Visit stripesbeauty.com and use the code COMMUNE20 for 20% off our entire product line.

A flat CGM line isn't always good news. Episode #267

Send us Fan MailToday's podcast is about humility and its role in spiritual warfare. Our scripture is Daniel Chapter 4:37b, "And those who walk in pride he is able to humble." These are the words of King Nebuchadnezzar II as he spoke about God.Nebuchadnezzar II was a Babylonian King who reigned from around 605 to 562 BCE. Among his many military conquests is the destruction of Jerusalem in 586 BCE. He is also known for his many ambitious building projects, including the Hanging Gardens of Babylon, one of the Seven Wonders of the Ancient World.He is also famous for his praise of God in the Book of Daniel, chapters 2-4. In chapter 2, after Daniel interprets the king's dream of an enormous statue, the king said, “Surely your God is the God of gods and the Lord of kings and a revealer of mysteries, for you were able to reveal this mystery.” In chapter three, the king saw the three Hebrew boys escape the fiery furnace he had thrown them into for defying his order to worship an idol statue. After they emerged from that fire unscathed, Nebuchadnezzar said, “Praise be to the God of Shadrach, Meshach and Abednego, who has sent his angel and rescued his servants! They trusted in him and defied the king's command and were willing to give up their lives rather than serve or worship any god except their own God. Therefore I decree that the people of any nation or language who say anything against the God of Shadrach, Meshach and Abednego be cut into pieces, and their houses be turned into piles of rubble, for no other god can save in this way.”Again, in chapter four, the king pays homage to God, but only after he went mad for esteeming himself above the One, True God. After the king repented, his sanity was restored, and he said: “Now I, Nebuchadnezzar, praise and exalt and glorify the King of heaven, because everything he does is right and all his ways are just. And those who walk in pride he is able to humble.” Daniel 4:37 NIVWe can only hope that God reached Nebuchadnezzar in chapter 4. His humility lasted only a little while after chapter 2. It is believed that 20-30 years will pass before we reach chapter 4.These chapters, especially chapter four, are about being humble and subduing pride. The most compelling reason to be humble is that we are all going to die. Yes, we are all going back to dust.Humility is a spiritual warfare weapon because you cannot be successful in spiritual warfare without three things—first submitting to the will of God, then admitting that you can do nothing without Him, and finally, committing to do what He leads you to do after you submit and admit.Humility subdues pride and puts pride under your foot where it belongs because God hates a proud look. Thus, God cannot be present with you in spiritual warfare if you are garnered in pride.So, for success in spiritual warfare, cover your armor in humble submission to his will. And don't be like King Nebuchadnezzar, whose humility was temporary. Be steadfast and stay humble all the days of your life.If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Blood sugar is the master dial. If your energy crashes at 3pm, if the cravings run you, if the belly weight will not move no matter how clean you eat, this is not a willpower problem. It is a blood sugar problem, and it is fixable. In this episode I break down blood sugar for women from the ground up: what glucose and insulin actually do, the six levers that throw them off, the full diabetes spectrum from prediabetes through Types 1 to 4 (including the lean, skinny fat Type 4 that surprised me), and the exact labs and CGMs to run. Then I give you my full stack across four pillars: nutrition, lifestyle, supplements, and peptides. I also get into how the GLP-1s and the growth hormone peptides move your blood sugar in opposite directions, PMOS (the newly renamed condition you have known as PCOS) where insulin is the real root, and how to actually get a CGM here in Canada now that the US apps like Levels do not ship north of the border. If you want me to build this protocol with you, you can book a free call here.   Timestamps: 04:15 - What blood sugar is: glucose and insulin 07:38 - Lever 1: spikes, crashes, and cravings 11:31 - Lever 2: insulin, belly fat, and fat storage 15:45 - Lever 3: insulin resistance and HOMA-IR 19:17 - Lever 4: glycation and your HbA1c 24:04 - Lever 5: cortisol, how stress spikes sugar 26:29 - Lever 6: your hormones, cycle, and perimenopause 34:16 - The diabetes spectrum: prediabetes and Types 1 to 4 46:17 - Symptoms: how to tell your blood sugar is off 48:03 - Labs and CGMs, and how to get one in Canada 57:06 - Pillar 1: nutrition to flatten the spike 1:13:55 - Pillar 2: lifestyle, walking, muscle, sleep 1:18:45 - Pillar 3: supplements (magnesium, inositol, berberine) 1:25:43 - Pillar 4: peptides, GLP-1s, and PMOS Resources: Work with me one-on-one. The Her Stack Planner (digital or prints at home). My trusted Peptide Source Guide. Join The LongHer Life Longevity Community. Products mentioned: Run your labs with SiPhox Health (code BRITTANY20). Function Health full-body labs (US). NiaHealth labs (Canada). Baja Gold minerals and electrolytes. Code BIOHACKINGBRITTANY. Ovii Metabolic Sync. Code BIOHACKINGBRITTANY. Let's connect: Instagram, TikTok, Facebook Shop my favorite health products. Listen on Spotify, Apple Podcasts, YouTube Music. This is for educational purposes only. This is not medical advice.

Kate Makinson has lived with Type 1 diabetes since 7th grade and has spent the last 33 years building a life of absolute adventure. She's a PE teacher, runner, mountain biker, and someone who has always found a way to figure it out, whether that meant finishing a half marathon with a failing CGM or managing nine days in Europe after her insulin pump broke with nothing but short-acting insulin.After 12 years away from the diabetes community, raising two kids and focusing on her career, things started changing. When perimenopause hit, the symptoms looked so much like long-term diabetes complications that Kate convinced herself that was exactly what they were. That fear, after three decades of managing T1D with confidence, sent her looking for a T1D community she'd never thought she needed. She found it in Risely's group coaching program, where her average blood sugar dropped from 171 to 155, her time in range climbed from 61% to 75%, and her A1C improved from 7.5 to 6.9. But more than the numbers, Kate walked away with a mindset she hadn't had in years: that no matter what diabetes throws at you, you've got this.WHAT WE COVER:The specific habit that helped drop her average blood sugar from 171 to 155 and bring her time in range from 61% to 75%What it was like to spend nine days in Europe after her insulin pump broke with nothing but short-acting insulin, and how she managed to keep adventuring anywayHow a failing CGM in the first mile of a half marathon forced her to run 13 miles on instinct, gels, and sheer determinationWhy perimenopause symptoms convinced her she had long-term diabetes complicationsWhat brought her to Risely coaching after 33 years of managing T1D largely on her own, and why she says it was the support she didn't know she neededHer best travel tips for flying, international trips, and staying prepared without letting diabetes overthink the adventureWHAT'S NEXT:

The fastest way to change your glucose numbers might not be another food rule. It might be muscle. Today, we get practical about strength training and why it's a foundational lever for metabolic health, weight loss results, and better day-to-day energy.I'm joined by Signos' clinical lead and scientific advisor, Dr. Gray Strike, who has a PhD in nutrition and exercise physiology. We start by dismantling the fear that lifting automatically makes you bulky, then define what resistance training actually is: challenging your muscles against a force with progressive overload over time. We even run through common workouts people ask about, from bands and bodyweight to Pilates-style classes, to clarify what truly builds strength.From there, we connect the dots to glucose control. Dr. Strike explains why muscle acts like a sponge for glucose, how exercise can improve insulin sensitivity, and why muscle glycogen storage matters when you're trying to reduce spikes on a continuous glucose monitor (CGM). We also zoom out to the bigger picture: mental health, sleep, longevity, and the real-world abilities strength protects as you age.Finally, we address weight management myths and the GLP-1 movement. If the scale rises when you start lifting, we explain what to track instead, why body composition beats BMI, and why preserving lean mass is critical, especially for anyone using GLP-1 medications. Press play for a simple, low-pressure plan to start with bodyweight at home and build from there, then subscribe, share this with a friend who “hates lifting,” and leave a review so more people can find the show.Click Here to pre-order a copy of my new book The Glucose Edge. 

In today's episode, the conversation leads into something Ken feels deeply — the frustration of hearing people claim that Type 1 diabetes can be cured. As an autoimmune condition, Type 1 operates differently than Type 2, and the constant lumping together of both conditions by researchers, politicians, and the media creates real harm for people navigating the daily reality of living insulin dependent. Ken makes the case for why the principles of good health apply to everyone — but the mechanisms, and especially the medication piece, are not the same.Then the episode shifts into one of the most practical conversations Ken and Graham have had — the real tradeoffs between wearing a CGM and going without one. Graham has chosen to step away from CGM and rely on finger sticks and MDI, and Ken respects that. But he also gets honest about what that choice means when it comes to getting meaningful support from your endocrinologist. Without continuous data, your doctor is working with a handful of snapshots. With it, they can see the full picture — and that changes everything about the quality of care you can receive.

A teenager takes her CGM off the summer after diagnosis and never puts it back — three years of finger sticks by choice, and a mom learning when to step back. ABLEnow save for today's needs or invest for tomorrow Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Summer doesn't have to be a season you recover from. Episode #265

As over-the-counter continuous glucose monitors (CGMs) become more common, clinician guidance matters more than ever. In this episode of BackTable Women's Health, Dr. Nicole Faulkner welcomes Dr. Nicholas Canelo, a family medicine physician and founder of the Perlman Wellness CGM program, to discuss how to effectively guide CGM use in OBGYN practice, from preconception and PCOS to pregnancy and perimenopause. They highlight the importance of interpreting data trends, setting realistic glucose targets, and supporting patients through the practical and emotional challenges of CGM use. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction04:58 - CGMs in Women's Health07:33 - OTC Data Sharing Issues09:52 - Pregnancy Glucose Targets16:20 - Accuracy and Variability20:10 - Anxiety and Eating Disorders24:41 - Counseling and Follow-Up28:29 - Prescription and OTC CGM Picks37:24 - False Lows and Sensor Errors41:23 - Alarm Settings and Logging44:06 - Interpreting Metrics and Limits46:44 - Provider Dashboards 48:42 - Final Thoughts --- More about this episode Given the lack of well-established blood glucose targets outside of type 1 diabetes, Dr. Canelo reviews commonly used ranges for individuals without diabetes, those with prediabetes, and pregnant patients with type 1 or 2 diabetes. He explains how to interpret CGM data, including the time in tight range, coefficient of variation, and the importance of focusing on overall trends rather than isolated glucose spikes. They also discuss the potential drawbacks associated with CGM use, including anxiety and eating-disorder risks. Practical considerations include sensor inaccuracies, false lows readings, and optimizing alarm settings. Dr. Canelo emphasizes the importance of having patients log meals and other events while wearing the sensor and scheduling follow-up after the initial 15-day wear period to ensure accurate interpretation and effective counseling. Finally, they compare OTC and prescription CGM options, including costs, clinician access to patient data, and insertion tips. --- Resources Stelo - Over the Counter CGM Optionhttps://www.stelo.com/en-us --- BackTable Women's Health is the go-to podcast for gynecologists, gynecologic surgeons, and other healthcare professionals focused on women's health. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Można Pięknie Żyć *---Witaj! "Można Pięknie Żyć*" to seria podcastów, w której odkrywamy, jak zmiany w stylu życia mogą poprawić nasze zdrowie metaboliczne. Skupiamy się na Terapeutycznym Ograniczaniu Węglowodanów i jego pozytywnym wpływie na metabolizm oraz ogólne samopoczucie. Pamiętaj, że zdrowie zaczyna się od wiedzy, a my jesteśmy tu, aby dostarczać Ci inspirację i praktyczne wskazówki na drodze do pięknego życia. Zaczynamy!  Czy wiesz, że ponad 50% Polaków (czyli około 11 milionów dorosłych osób) zmaga się z insulinoopornością, a większość z nich nie ma o tym zielonego pojęcia? Co gorsza, obecny system ochrony zdrowia nie refunduje kluczowych badań diagnostycznych, a w gabinetach lekarskich wciąż możesz usłyszeć przestarzałe, szkodliwe porady, które tylko pogłębiają problem. W tym odcinku udowadniamy, że insulinooporność to nie jest żadna „chwilowa moda”, ale realna, cicha pandemia i bezpośrednia przyczyna większości problemów metabolicznych.Z tego odcinka dowiesz się: ·       Jedna przyczyna wielu chorób – Zobaczysz, dlaczego schorzenia takie jak cukrzyca typu drugiego, otyłość brzuszna, nadciśnienie tętnicze, stłuszczenie wątroby czy PCOS to nie są osobne diagnozy, a jedynie objawy tego samego zaburzenia metabolicznego.·       Insulina a każda komórka ciała – Poznasz dowód naukowy na to, dlaczego ten jeden hormon rządzi całym Twoim organizmem.·     Krzywe insulinowe Krafta – Nauczysz się prawidłowo interpretować wyniki po obciążeniu  glukozy. Dowiesz się, dlaczego prawidłowy cukier na czczo potrafi latami maskować zaawansowaną chorobę (wzorzec ukrytej hiperinsulinemii).·       Podamy Tobie również 3 proste zalecenia, które powinieneś wdrożyć żeby wycofać insulinooporność.·       Historia sukcesu pani Krystyny – Poznasz poruszający przypadek 65-letniej pacjentki z wielochorobowością (cukrzyca od 20 lat, Hashimoto, niewydolność nerek i serca). Zobaczysz, jak dzięki zmianie paradygmatu żywienia oraz wsparciu ciągłego monitoringu glukozy (CGM) odstawiła insulinę i całkowicie wycofała chorobę.LINK DO PRZEPISU : https://www.youtube.com/watch?v=klc2DHbddIs  Polub i udostępnij ten odcinek, aby pomóc nam promować niezależną wiedzę, i odpowiedz w komentarzu na pytanie zadane w filmie!UWAGA! Bilety na Low Carb Festival.  WYPRZEDANE zapisz się do listy oczekujących.Low Carb Festival To #1 Największe Na Świecie wydarzenie Dotyczące Odżywiania Niskowęglowodanowego

Rob was at ADA 2026 in spirit — armed with press access and a list of questions unrelated to the usual conference talking points. His first guest from that coverage is Jake Leach, Dexcom's new CEO, who took over the role on January 1st after 22 years at the company. This is Jake's first time on Diabetics Doing Things as CEO. It sounds like two people having a real conversation about what it means to lead a company that millions of people with diabetes depend on every single day. They get into the research that came out of this year's scientific sessions — specifically, the CONNECT trial, a global randomized controlled study that examined what happens when people with type 2 diabetes who aren't using insulin start using the Dexcom G7. The numbers are striking: an average 1.6% reduction in HbA1C, 5 additional hours per day in range, and 97% sensor utilization over 6 months. That last number might be the most telling — it answers the question the diabetes world has been asking for years about whether people without hypoglycemia risk would actually wear a CGM consistently. Turns out, they will. Rob also pushes the conversation into territory that most executive interviews don't touch. When Dexcom products intended for destruction were stolen and resold to patients, Jake had to go from leading conference sessions to serving as something closer to a chief detective. His candid answer about feeling genuinely betrayed — and how the newly launched Customer Advisory Council became an unexpected asset in getting the word out — is one of the more honest moments you'll hear from a medical device CEO. The council itself, publicly announced and facilitated externally to get truly unfiltered feedback, is something Jake stood up as one of his first acts as CEO. They close on the bigger picture: G8 on the horizon (half the size of G7, with adaptive sensor technology that auto-corrects signal drift), the Nutrisense acquisition adding nutrition coaching to the platform, and where Jake sees Dexcom going as it scales toward serving hundreds of millions of people globally. If you've ever wondered what the person at the top of your CGM company is actually thinking about, this episode gives you a pretty clear answer. Chapters: 00:00 Rob sets up ADA 2026 remote coverage 01:46 Welcoming Dexcom CEO Jake Leach back 02:30 First 90 days: Jake's three CEO priorities 04:39 The Customer Advisory Council goes public 06:47 What the council revealed about communication gaps 08:44 Stolen sensors: Jake's personal reaction 10:39 How the council helped contain the crisis 11:20 CONNECT trial: CGM for non-insulin type 2 users 15:16 97% adherence and five more hours in range daily 16:16 G8 preview: smaller, smarter, adaptive sensing 16:44 Acquiring Nutrisense and redesigning the app experience 19:52 Optimizing beyond insulin: smart bolus and GLP-1s 21:13 Why CGM and GLP-1s are surprisingly powerful together 22:27 Jake's long-term vision for Dexcom's global impact 24:14 Transparency as the foundation of high-performance culture Resources: * Dexcom — dexcom.com | Follow Jake and the team for updates on G8, Stello, and the Customer Advisory Council findings * CONNECT Trial — The full study results from ADA 2026 Scientific Sessions.

We kick off summer by breaking down how heat, sun, and seasonal routines can change glucose in surprising ways. We share practical CGM-focused strategies for hydration, summer foods, barbecues, and outdoor workouts so you can enjoy the season and still learn what your metabolism is doing. Some topics we cover: • How heat exposure can raise and at time lower your circulating glucose • Why hydration and specifically electrolytes are key to keeping your glucose in range• How frozen fruit as a practical way to get more color and nutrients • Summer barbecue nutrition strategies• How alcohol can delay spikes and make overeating easier •Summer sports basics including fueling, carrying snacks, and staying ahead on fluids My next book The Glucose Edge is available for pre-order, shipping on December 15, 2026. You can pre-order now on Amazon, Barnes and Noble, or wherever fine books are sold. If you enjoy our show, please like and subscribe to this podcast. 

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin, and Philip's dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen.The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day.Dr. Edelman and Dr. Cymbaluk also explore how Afrezza is dosed, how inhaled insulin differs from injected insulin, who may be a good candidate, and where it may fit alongside pumps and automated insulin delivery (AID) systems. For families looking for more flexibility, fewer mealtime barriers, and another option in the diabetes toolbox, this episode provides an honest look at the benefits, limitations, and real-world experience of inhaled insulin in children and teens.Key Topics• The FDA approval of Afrezza for children and adolescents living with type 1 diabetes• The design and results of the INHALE-1 pediatric clinical trial• Patient satisfaction and quality-of-life outcomes from the study• The challenges of pre-bolusing and mealtime insulin management in children and teens• How inhaled insulin compares to traditional mealtime injections• Dosing strategies, cartridge sizes, and insulin conversion considerations• Using Afrezza for corrections, meals, and post-meal dosing• The role of continuous glucose monitoring (CGM) when using inhaled insulin• Safety findings, lung-function monitoring, and cough management• Who may be a good candidate for Afrezza—and who may not be• Benefits for active children, athletes, and those participating in sports• Social situations, injection avoidance, and reducing the burden of diabetes management• Using Afrezza alongside insulin pumps and automated insulin delivery (AID) systems• The importance of having more treatment options to individualize diabetes careSupported by an unrestricted educational grant from MannKind CorporationSubscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

In this episode, Ken and Graham have an honest conversation about one of the biggest challenges of living with Type 1 diabetes:The mental load of making thousands of decisions every single day.Diabetes isn't just insulin, food, and numbers. It's constant troubleshooting, analyzing patterns, adjusting plans, and trying to figure out why something happened when diabetes doesn't always follow the rules.Graham shares the frustration of feeling like diabetes becomes an endless series of “projects”—testing different foods, analyzing patterns, and trying to understand why things work one day but not the next. That conversation leads into a deeper discussion about diabetes burnout and the exhaustion that comes from always trying to solve the next problem.Ken explains his approach to reducing that mental burden through diabetes checklists—a framework he uses to help people stop reacting emotionally and start working through problems systematically.Whether it's a CGM that isn't working correctly, an insulin pump issue, or unexpected blood sugar changes, the goal isn't to eliminate every problem. The goal is to have a process that helps you make better decisions when those problems happen.This episode is a reminder that confidence with diabetes doesn't come from having perfect numbers—it comes from knowing how to respond when things don't go according to plan.

In this episode of Intermittent Fasting Stories, Gin to Richard Flores from Abilene, TX.Join Gin in the new Fast Feast Repeat app for The Grown-Up Year: 52 Weeks to Listen, Play, and Nourish, as well as a growing collection of intermittent fasting resources. Go to app.fastfeastrepeat.com to join us or go to the App Store and download the Fast Feast Repeat app, available for both iPhone and Android.Are you ready to take your intermittent fasting lifestyle to the next level? There's nothing better than community to help with that. In the Delay, Don't Deny community we all embrace the clean fast, and there's just the right support for you as you live your intermittent fasting lifestyle. You can connect directly with Gin in the Ask Gin group, and she will answer all of your questions personally. If you're new to intermittent fasting or recommitting to the IF lifestyle, join the 28-Day FAST Start group. After your fast start, join us for support in The 1st Year group. Need tips for long term maintenance? We have a place for that! There are many more useful spaces beyond these, and you can interact in as many as you like. Visit ginstephens.com/community to join us. An annual membership costs just over a dollar a week when you do the math. If you aren't ready to fully commit for a year, join for a month and you can cancel at any time. If you know you'll want to stay forever, we also have a lifetime membership option available. IF is free. You don't need to join our community to fast. But if you're looking for support from a community of like-minded IFers, we are here for you at ginstephens.com/community. Richard is an architect. He shares how a Christmas trip and a growing awareness of his health concerns pushed him to make a change at the start of 2024. What began as a few days of fasting in solidarity with his daughter's medical prep eventually led him to Gin Stephens' books, then into intermittent fasting. He began on Labor Day of 2024 with the 28-day Fast Start Day by Day book. He explains that the early days were hard, but having a day-by-day roadmap helped him stay committed when his old habits and fears about hunger tried to pull him back.As Richard kept going, he lost weight, moved through plateaus, and started uncovering the deeper reasons he had used food for comfort, celebration, and convenience. He talks openly about a lifelong pattern of oversized portions, family food traditions, and the mental tug of wanting to “finish what's on the plate,” and how fasting has helped him break that cycle. A CGM also gave him a powerful wake-up call, showing him how certain breads, buns, and sugary drinks spiked his glucose and left him crashing, while simpler meals with protein and vegetables kept him satisfied much longer.Richard's story becomes especially encouraging in the way fasting has changed how he lives, not just how he eats. He's stronger, walking more, running in short bursts again, and even planning hikes and more joyful movement like dancing, because he wants fitness to feel fun rather than punishing. He closes with the advice that new intermittent fasters should jump in and start now, because waiting for the “perfect” time only delays the change they want.Join Gin in the new Fast Feast Repeat app for The Grown-Up Year: 52 Weeks to Listen, Play, and Nourish, as well as a growing collection of intermittent fasting resources. Go to app.fastfeastrepeat.com to join us or go to the App Store and download the Fast Feast Repeat app, available for both iPhone and Android.Get Gin's books at: https://www.ginstephens.com/get-the-books.html. Good news! The second edition of Delay, Don't Deny is now available in ebook, paperback, hardback, and audiobook. This is the book that you'll want to start with or share with others, as it is a simple introduction to IF. It's been updated to include the clean fast, an easier to understand and more thorough description of ADF and all of your ADF options, and an all new success stories section. When shopping, make sure to get the second edition, which has a 2024 publication date. The audiobook for the second edition is available now! Join Gin's community! Go to: ginstephens.com/communityDo you enjoy Intermittent Fasting Stories? You'll probably also like Gin's other podcast with cohost Sheri Bullock: Fast. Feast. Repeat. Intermittent Fasting for Life. Find it wherever you listen to podcasts. Share your intermittent fasting stories with Gin: gin@intermittentfastingstories.comVisit Gin's website at: ginstephens.com Check out Gin's Favorite Things at http://www.ginstephens.com/gins-favorite-things.htmlSubscribe to Gin's YouTube Channel! https://www.youtube.com/channel/UC_frGNiTEoJ88rZOwvuG2CASee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us Fan MailHello and welcome to CGM Presents: In the Word. My name is Dr. Stephanie Wright. On behalf of Charles George Missions, welcome to “Spiritual Warfare Scriptures.” The resource for this series is the Word of God—the Bible—and the book “Spiritual Warfare Manual: ABC to PhD,” written by yours truly.Today's spiritual warfare scripture is about faith, which comes from Ephesians 6, verse 16, and reads:Above all, taking the shield of faith, wherewith ye shall be able to quench all the fiery darts of the wicked.Faith is a spiritual warfare weapon because we use it to quench ALL the fiery dart of the enemy. All means all, and that's all that all means.But it is our faith in God that will bring us through all fiery trials.Can you recall the most fiery test or trial that you have been through since the Lord came into your life? Did you recall this scripture on faith when you went through that test?Ephesians 6, verses 13-17 are among the most influential scriptures on spiritual warfare—they tell us to put on the whole armor of God.But as we stay focused on the shield of faith and quenching the fiery darts of Satan's attacks, I think about the Hebrew boys in Daniel, Chapter 3. Theirs was the seminal case for true faith in God. When they were thrown into the fire, they had the Angel of the Lord as their shield, which some believe was the pre-incarnate Jesus. When they came out of that fire, Daniel 3:27 said the fire had no power over their bodies, “nor was a hair of their head singed, neither were their coats changed, nor the smell of fire had passed on them.”So, it is with us when we use the shield of faith to quench the fiery darts of our enemies. Jesus will be with us in the fire, through the fire, and when we come out of the fire. He will never leave us nor forsake us. Hebrews 13:5. And when we come out of our test—as some saints say—we won't look like what we've been through either.So, remember Ephesians 6:16 the next time you face a fiery trial. Above all, take the shield of faith, wherewith ye shall be able to quench all the fiery darts of the wicked.And please remember the key phrase in that verse—”all the fiery darts”—because all means all the fiery darts, no exclusions.Thank you for joining us today.Now, let's turn to Dr. Charles Wright, who will tell you how you may reach us and comment on this podcast.Until next time.The quote "All means all and that's all that all means" is attributed to Brother Jason Hill from a Wednesday night Bible study that Dr. Charles and I taught. If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

This is a Premium-exclusive episode. Go to the Premium feed to listen. Or subscribe to Premium. Blood glucose is easy to measure, but not always easy to interpret. This Premium-only episode brings together insights from several previous guests to examine blood glucose responses in more detail. We discuss the misuse of clinical thresholds, the difference between OGTT results and free-living CGM data, and whether "flatter" glucose curves are actually better in normoglycemic people. The episode also covers when repeated high glucose excursions may be worth investigating, how sugar intake should be interpreted in context, and why skeletal muscle and exercise play such an important role in glucose regulation. Overall, the aim is to clarify what glucose responses can tell us, what they cannot tell us, and how to avoid pathologizing normal physiology. Links:  Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course

Career exploration often starts with enthusiasm but stalls at the exact point where clarity is supposed to take shape.In this solo episode, Lisa Marker-Robbins shares a pattern she has observed after helping thousands of families, from those who have no idea where to start to those who believe they're checking all the right boxes: young people rarely get stuck because they lack information.Instead, the biggest roadblock appears when it's time to move beyond assessments and online research into real-world career validation. Lisa explains why this stage feels difficult for teens, college students, and young adults. Using a personal continuous glucose monitor (CGM) experiment as an analogy, she illustrates the difference between awareness and validation and previews why courage becomes the next essential step in the career development process.In this episode, you'll discover:The hidden challenges that emerge after an initial career interest takes shapeWhy career confidence is built differently than most families expectThe role discomfort plays in major life and career decisionsHow parents can better interpret periods of stalled progressKey Takeaways: Whether families are just beginning the career conversation or feel they're doing everything right, the validation stage is where many students and young adults lose momentum.A student's willingness to complete assessments and research careers is often evidence of engagement, which means stalled progress is more likely tied to discomfort with the next step than a lack of motivation.Real career confidence is built through validation experiences such as informational conversations, job shadows, internships, part-time work, and other forms of firsthand exposure that test assumptions against reality.Awareness comes from gathering information, but confidence grows when ideas are tested in real-world situations and assumptions are replaced with firsthand experience. “If you skip steps, you skip results, and that's where things fall apart.” – Lisa Marker-RobbinsGet Lisa's Free on-demand video: THE CAREER IDENTIFICATION COMPASS: How To Be Certain Your 15 To 25 Year Old is On The Right Path to Launch With Confidence–Not Confusion: flourishcoachingco.com/video  Connect with Lisa:Website: https://www.flourishcoachingco.com/YouTube: https://www.youtube.com/@flourishcoachingcoFacebook: https://www.facebook.com/flourishcoachingco/ Instagram: https://www.instagram.com/flourishcoachingco/LinkedIn: https://www.linkedin.com/company/flourish-coaching-co

"Making the effort earlier totally changes the trajectory for the rest of your life,” says Jeremy London, MD. London is a board-certified cardiovascular surgeon with more than 25 years of clinical experience caring for patients across the full spectrum of heart disease — from prevention to advanced intervention. Dr. London received his medical degree from the Medical College of Georgia and completed his general surgery residency at Joseph's Hospital in Denver, Colorado. He completed a general vascular and thoracic surgical fellowship at the Carolinas Medical Center in Charlotte, N.C. To deepen his understanding of medicine, he completed the Institute of Functional Medicine core program. 00:00 - When a cardiac surgeon has a heart attack 10:46 - Waking up with different priorities 13:49 - Missed signals 18:35 - The CGM experiment that revealed pre-diabetes 21:43 - The 5 tests that actually matter 25:44 - Diving into Lp(a) 30:36 - Target numbers for primary prevention 32:26 - Why taking medication isn't failure 38:24 - Atherosclerosis starts in childhood 41:19 - Why a zero calcium score doesn't mean you're safe 45:40 - What we don't know 48:41 - GLP-1s & the future of prevention For more about London, visit his website: https://drjeremylondon.com/  We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us Fan MailHello and welcome to CGM Presents: In the Word. My name is Dr. Stephanie Wright. On behalf of Charles George Missions, welcome to “Spiritual Warfare Scriptures.” The resource for this series is the Word of God—the Bible—and the book “Spiritual Warfare Manual: ABC to PhD,” written by yours truly.Today's spiritual warfare scripture is about trust. Proverbs 3:5-6 reads:"Trust in the LORD with all your heart; And lean not to your own understanding. In all your ways acknowledge him, And he shall direct your paths.”Trust is a spiritual warfare weapon because we have to trust God in our spiritual battles. Compare this in the natural to the military soldier who trusts his commanders and fellow soldiers in war.One example of spiritual and military warfare is the experience of Dr. Charles Wright, as recounted on pages 60-61 of Spiritual Warfare Manual: ABC to PhD.Reading by CharlesThank you for joining us today.Now, let's turn to Dr. Charles Wright, who will tell you how you may reach us and comment on this podcast.Until next time.If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Emily spent months farming in Tennessee, attributing her extreme thirst to an electrolyte imbalance. Today, she shares her grounded, "roll with it" approach to managing Type 1 diabetes. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 ABLEnow save for today's needs or invest for tomorrow Tandem Mobi  Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

This episode breaks down gestational diabetes (new insulin resistance in pregnancy—not type 1 or 2), how insulin and glucose work, and why pregnancy naturally raises insulin resistance (but sometimes the pancreas can't keep up). It covers who's at higher risk (higher BMI, inactivity, prior GDM, certain ethnic groups, prior 9+ lb baby, PCOS, hypertension, heart disease) and how screening works at 24–28 weeks: the non-fasting 1-hour 50g test, followed by a fasting 3-hour 100g test if you “fail” (two elevated values = diagnosis). It explains why the test is a glucose “stress test,” alternatives like at-home fingersticks or CGM, and drink options (Glucola, Fresh Test, jelly beans). Finally, it outlines risks (C-section, shoulder dystocia, preeclampsia, baby hypoglycemia) and care differences between diet-controlled (deliver by 40+6) vs medication-controlled (NSTs/ultrasounds ~32 weeks, deliver ~39).00:00 Gestational Diabetes Overview00:52 How Insulin Works02:31 Risk Factors Explained03:20 Glucose Test Basics05:43 One Hour vs Three Hour07:06 At Home Monitoring Options09:42 Drink Alternatives13:52 Why It Matters Risks18:46 How Care Changes21:27 Final Recap Next Steps24:24 Closing Resources————

When mutual friends in the diabetes community kept telling Rob he had a doppelganger in LA, he figured they were exaggerating. Then he met Dylan Leonard — creative director, documentary filmmaker, college basketball player, type one diabetic, philosophy reader, world traveler — and yeah, the comparisons held up pretty well. Dylan was diagnosed at 15, having dropped 45 pounds before anyone realized something was wrong. He went from a hospital bed thinking he'd never eat sugar again to playing college basketball while managing T1D without a CGM, without a pump, and without knowing a single other person with diabetes for his first decade. What carried him through was activity — six hours of workouts a day during basketball season — and a mindset he's been intentionally building ever since through reading, travel, and genuinely hard conversations with himself. This episode goes wide. Rob and Dylan dig into Dylan's upcoming documentary Breaking Limits: Life on the Edge, which follows elite athletes with type one diabetes across seven different sports — from Olympic competitors to IndyCar drivers to American Ninja Warriors. Dylan invested his own money and thousands of hours into this project, not to make a cent, but to hand a 15-year-old sitting in a hospital bed the resource he never had. They also get into the philosophy of travel as the cheapest education on earth, why our brains literally haven't caught up to the abundance of modern life, the difference between manifesting and obsessing, and what a five-hour train conversation with a Norwegian stranger taught Dylan about human connection. Oh, and they're making plans to run a hoop session next time Rob's in LA. Cameras included. Chapters: 00:00 Rob's T1D doppelganger, meet Dylan 01:49 Dylan introduces himself: creative, hooper, T1D 02:39 Dylan's diagnosis story: 45 lbs lost at 15 04:36 First pickup game post-diagnosis, flying blind 06:26 How activity literally saved his diabetes management 07:28 Life after college ball: blood sugars out of whack 09:12 Morning routine: walk, no phone, delayed caffeine 10:34 Civilized to Death and the myth of progress 14:48 Our brains weren't built for this level of abundance 17:21 Phones, phones everywhere — even for T1D management 19:45 Abundance mindset, FOMO, and the creative career trap 21:01 Why athletes list it: delayed gratification is a superpower 24:20 Self-help books, repetition, and finding what actually works2 7:48 Manifestation is obsession with action behind it 29:15 Compounding growth: who were we six years ago? 33:14 Breaking Limits documentary: T1D athletes across seven sports 38:59 Nine months of travel: Vietnam, Norway, Australia, Mexico 40:00 "The cheapest education on earth is a one-way flight" 44:44 Japan and what loneliness taught him about human connection Resources: * Dylan Leonard on Instagram * Civilized to Death by Christopher Ryan — the book Dylan cites on the myth of perpetual progress and why foraging societies may have been happier than ours * The Game of Life and How to Play It by Florence Scovel Shinn — Dylan's twice-a-year read, ~95 pages, written 100 years ago, still hitting * Risley Health / Rising Above T1D — where Dylan has previously appeared on podcast and debuted early cuts of Breaking Limits (link to Riseley Health podcast)

It's In The News - a look at the top diabetes stories and headlines happening now!   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: fall Detroit and Seattle.   Okay.. our top story this week: XX The FDA approved Tzield for use in stage 3 T1D – that's what we used to just call type 1. It's the stage where the body can no longer produce enough insulin on its own to manage blood sugars you need to start insulin. This approval is for kids ages 8-17 within 8 weeks of a stage 3 T1D diagnosis. It comes after the PROTECT trial and it's the first approval of a disease-modifying therapy for stage 3 T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-celebrates-approval-of-tzield-for-use-in-stage-3-type-1-diabetes-in-the-us-302799532.html XX Encouraging results from a small study of islet cell transplantation in people with type 1 where now all 12 participants in the trial are currently living without external insulin after receiving transplanted insulin-producing islet cells.   The study, led by researchers at the University of Chicago, tested an experimental immune therapy called tegoprubart Te-GO-Proo-Bart. The drug is designed to prevent the body from rejecting transplanted cells while avoiding some of the side effects associated with standard anti-rejection medications. You've probably heard about this as the Eledon study – many of the participants have been very active on social media. It was presented at ADA. transplants.https://www.breakthrought1d.org/news-and-updates/tegoprubart-islet-transplant-all-participants-off-external-insulin/ XX New data suggest that acmopatide (ack-MOW-puh-tyd) (CT-868), an experimental once-daily dual GLP-1/GIP receptor agonist, may help people with type 1 diabetes improve blood sugar control, lose weight, and reduce insulin use. Across all doses, participants lost up to 7% of their body weight and reduced insulin use by as much as 15%. The study lasted just 16 weeks, so researchers say longer-term data will be needed to determine whether the benefits can be maintained and whether lower insulin requirements can be achieved without increasing the risk of hypoglycemia. XX A new combination therapy that pairs an amylin analog with semaglutide improved both blood sugar levels and weight loss in several groups of people with type 2 diabetes. The once-weekly injectable, known as CagriSema (KAG-ruh-SEM-uh), was evaluated in three Phase 3 REIMAGINE studies. In people early in the course of type 2 diabetes, researchers reported A1C reductions of up to 1.8 percentage points and significant weight loss compared to placebo after 40 weeks of treatment. Investigators also noted improvements in several cardiometabolic risk factors, including blood pressure. https://www.medpagetoday.com/meetingcoverage/ada/121658 XX Stelo for kids is now FDA cleared.. the over the counter Glucose Biosensor System is now approved for children as young as 2 years old who do not use insulin. The FDA identified pediatric prediabetes as a growing public health concern motivating the expanded indication, noting OTC CGMs can help younger users and their caregivers build glycemic awareness, track patterns in response to me https://www.hcplive.com/view/fda-clears-first-otc-glucose-monitor-for-children XX Insulet presented new data from its STRIVE and EVOLUTION 3 studies showing improved glucose control with its next-generation Omnipod 6. That's , the company's upcoming hybrid closed-loop system for people with type 1 and type 2 diabetes. The main difference between the Omnipod 6 and Insulet's current Omnipod 5 patch pumps is that the new system has a lower glucose target of 100 mg/dL and better Bluetooth connectivity Insulet also shared progress on a fully closed-loop system designed specifically for type 2 diabetes. It  does not require carb-counting or insulin bolusing ahead of meals. Physicians also don't need to program the starting settings.   XX Abbott shared new research highlighting challenges in identifying and managing diabetic ketoacidosis (DKA). The studies coincide with the company's development of Libre Duo, a dual glucose-ketone sensor that continuously tracks both measurements. Abbott reported that DKA can be difficult to recognize when patients first arrive at the hospital, based on data from more than 100,000 people. The company has submitted the dual sensor to the FDA and recently received CE Mark approval in Europe. More news from ADA including info from Dexcom, Sequel, Sensonics and the world loses a tireless T1D advocate.. that's all to come right after this. --   Back to the news.. XX   Dexcom announced its acquisition of Nutrisense, a company that combines continuous glucose monitoring with nutrition coaching and behavioral support. At ADA, the company also presented results from the CONNECT study showing significant A1C reductions and improved glucose control in people with type 2 diabetes not using insulin. The findings add to growing evidence supporting CGM use beyond intensive insulin therapy. We did an episode with CEO Jake Leach at ADA about these announcements as well as updates on G8, their hospital product and much more. XX Sequel Med Tech reported positive clinical results evaluating its twiist automated insulin delivery system in people with type 2 diabetes. The study showed improvements in A1C and time in range over 13 weeks XX Senseonics presented new real-world data supporting the performance of its Eversense 365 implantable CGM. The analysis included more than 12,000 sensors and demonstrated sustained accuracy and effectiveness in both open-loop and automated insulin delivery settings. Researchers also evaluated Eversense use with Sequel Med Tech's twiist system. The findings support broader use of long-term implantable CGM technology.   -- MiniMed used ADA 2026 to spotlight two recently cleared diabetes management systems. The MiniMed Flex pump offers a smaller, smartphone-controlled insulin pump option, while MiniMed Go combines the InPen smart insulin pen with Abbott's Instinct sensor. The products received FDA clearance earlier this year. XX Tandem Diabetes Care highlighted data supporting the use of its Control-IQ automated insulin delivery technology during pregnancy. Results from the CIRCUIT trial showed users spent approximately three additional hours per day in the recommended pregnancy glucose range compared with standard therapy. The findings helped support recent regulatory approvals for pregnancy use in both Europe and the United States. Tandem also expanded indications for adults with type 2 diabetes. XX Beta Bionics presented real-world data from the first three years of iLet Bionic Pancreas use. The company reported a 25% improvement in time in range among users, along with positive feedback from clinicians about simplified diabetes management. The iLet system requires only a user's weight to begin therapy and eliminates carbohydrate counting. Beta Bionics also highlighted growing access to near-real-time outcomes through its public data dashboard. XX MannKind presented new findings supporting its Afrezza inhaled insulin at ADA 2026. A post-hoc analysis of the INHALE-1 study found that pediatric users reported greater treatment satisfaction compared with those using rapid-acting injected insulin. The results come shortly after FDA approval expanded Afrezza's indication to include children. We did a bonus episode with one of the lead investigators of the study that lead to that approval. XX Adaptyx presented early clinical data supporting a wearable sensor that continuously measures cortisol levels. The device successfully tracked cortisol changes during both controlled testing and overnight monitoring in first-in-human studies. Company leaders say cortisol plays a major role in conditions including diabetes, hypertension, and depression. The technology uses synthetic DNA-based molecular switches to generate real-time readings.   XX Biolinq shared new clinical findings for its Shine continuous glucose monitoring system. The needle-free device combines glucose monitoring with activity and sleep tracking .The system received FDA clearance in 2025. They're also looking at measuring lactate through the sensor. XX Long-time T1D advocate Kent Schnakenberg died last week. Schnakenberg was known in his community for using his love of bicycling to raise awareness of Type 1 diabetes. He also advocated for improving the lives of those living with the disease. Inspired by his niece, Michelle, who was diagnosed with juvenile diabetes when she was 13 years old, since 2014 he has traveled around the country cycling thousands of miles, speaking to hundreds and hundreds of kids and raising Money. According to Schnakenberg's family, he suffered a head trauma incident in his home on Wednesday. I spoke to Kent years ago – I believe the first year of the podcast. A sad loss but wonderful to see so many tributes and memories posted on social media in the last few days. https://diabetes-connections.com/john-costik-co-creator-of-nightscout-team-schnak/ https://www.wibw.com/2026/06/12/team-schnak-founder-kent-schnakenberg-passes-away/ XX And finally. Alexander Zverev (ts-ver-uhv) won the French Open, his first Grand Slam title. He lives with type 1, he paused a couple of time to check his blood sugar. He was diagnosed at age 4 and partners with Medtronic. "Becoming a professional tennis player was always my dream," Zverev shared in an article posted by Medtronic. "Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That's why I'm partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want." He also has a foundation committed to children with type 1 diabetes. Among other things, the life-saving insulin and other essential drugs are provided – also in developing countries." https://www.mensjournal.com/news/alexander-zverev-diabetes-wins-french-open-2026-medical-condition

 Most people with type 1 diabetes are told: “just have a snack before exercise.” But blood sugars are far more complex than that.I ran a real experiment using a CGM—intentionally spiked my glucose, then brought it back down using exercise. The result? Almost exactly where I started.It's not guesswork. It's timing, volume, and understanding how your body responds. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

In this episode of the TCOYD Podcast, Dr. Edelman and Dr. Pettus are joined by pediatric endocrinologist Dr. Jamie Wood, medical director of pediatric diabetes at Rainbow Babies & Children's Hospital and an investigator on the INHALE-1 trial, to talk through inhaled insulin in kids and where it fits in real-world pediatric care.The conversation focuses on the recent approval of Afrezza for children as young as six, and what the INHALE-1 trial actually showed. Dr. Wood walks through the study design, A1C results, lung-function and safety data, and the practical aspects of dosing inhaled insulin in a pediatric population. Rather than positioning it as a replacement for injections or pumps, the discussion centers on finding the right fit for each child's needs, from the newly diagnosed kid with a needle phobia to the teen trying to dose discreetly during a 20-minute school lunch.Dr. E, Dr. P, and Dr. Wood also discuss the everyday realities that shape how this option is used, including the set-dose cartridge sizes, a titration approach refined in clinic, and how families are mixing and matching tools alongside automated insulin delivery. The takeaway is encouraging: there are more options than ever for managing mealtime insulin in kids, and this one may help fill some of the gaps left by injections and pumps.Key Topics • The recent approval of inhaled insulin for children as young as six • How the INHALE-1 pediatric trial was designed • A1C results and what the primary endpoint analysis showed • Continuous glucose monitor (CGM) metrics across the two groups • Lung-function (FEV1) monitoring and pediatric safety • Weight and body mass index (BMI) findings • Why mealtime dosing is a leading unmet need in pediatric type 1 diabetes (T1D) • The set-dose cartridge approach and how it reframes meal sizes • A real-world titration method for inhaled insulin • Managing cough and other practical considerations • Needle phobia and the kids who struggle most with injections • Using inhaled insulin alongside automated insulin delivery (AID) systems • What's coming next, including a smaller cartridge dose and a new-onset trial Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Your body after a baby was never a calorie problem. It is a metabolic one. In this Her Stack episode I am walking you through exactly how to restore your metabolism so body composition follows. The goal is not weight loss. The goal is metabolic restoration. Body comp is downstream. I am breaking down the four drivers that actually run body composition (insulin, thyroid, sleep, growth hormone), the four pillars to address them (nutrition, lifestyle, supplements, peptides), and the exact peptide sequencing for women. Plus my honest take on GLP-1s including semaglutide, tirzepatide, and retatrutide, where they actually fit, and why microdosing makes more sense than chasing the scale. I also share what nobody talks about. Eating less postpartum often makes body composition worse. Breastfeeding is sequencing, not failure. Growth hormone is the layer women never hear about, so they plateau and blame their age when it was a fixable signal the whole time. Join The LongHer Life for women-specific guidance on peptides, hormones, and longevity.   I TALK ABOUT: 00:00 Welcome back to the Her Stack series 00:53 Updates: working with me one-on-one and my new peptide planner 06:15 Why body composition not weight, and why metabolism not calories 07:01 The four drivers and four pillars framework 09:00 Driver 1: Insulin resistance and why stubborn middle fat is an insulin problem, not a calorie problem 11:30 Driver 2: Thyroid, and why TSH alone misses Free T3 (the worker hormone) 14:50 Driver 3: Sleep, cortisol, and the loop back to insulin resistance 19:32 Driver 4: Growth hormone, the layer nobody talks about that's blunted postpartum and through aging 22:19 The labs to actually ask for: fasting insulin, Free T3, IGF-1, DHEA-S, plus a 2-week CGM 24:30 Pillar 1: Nutrition (protein floor of 120g, leucine at every meal, food order, fiber, and why you should NOT under-eat) 28:06 Why leucine flips the muscle-building switch 35:00 Pillar 2: Lifestyle and biohacking (lift 3x a week, walk 7-10k steps, zone 2, cold and heat, red light, and the fringe tier honestly) 45:30 Pillar 3: Supplements (creatine, magnesium glycinate, myo-inositol, omega-3, berberine, and breastfeeding sequencing) 51:01 Berberine, AMPK, and "nature's metformin" 55:30 Pillar 4: The peptide stack starts here with AOD-9604 56:00 AOD-9604, the growth hormone fragment, why I am personally taking it right now 01:02:00 MOTS-c, the "exercise in a molecule" mitochondrial peptide 01:05:00 5-Amino-1MQ and releasing the brake on fat cells 01:07:00 Sermorelin, the gentle GH entry (what a secretagogue actually is) 01:10:00 CJC-1295, Ipamorelin, and Tesamorelin for post-weaning GH restoration 01:13:00 The GLP-1 honest take: semaglutide, tirzepatide, and the retatrutide question 01:14:00 Why retatrutide is called the triple agonist and where it fits (and where it doesn't) 01:19:27 Recap and wrap-up   RESOURCES: Work with me one-on-one on your peptide stack and protocol. The Her Stack Planner, the first peptide tracking journal built around female biology. Free Peptide Masterclass for Women. Join The LongHer Life for women-specific guidance on peptides, hormones, and longevity.   LET'S CONNECT: Instagram, TikTok, Facebook Shop my favorite health products Listen on Spotify, Apple Podcasts, YouTube Music

Sabrina discusses her vigilant approach to managing her two-year-old son Zevi's Type 1 diabetes. Listen as she navigates diluted insulin, looping, and "vibe bolusing" a toddler. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 ABLEnow save for today's needs or invest for tomorrow Tandem Mobi  Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Tyler Cook is a professional GT3 racing driver who has competed in some of the most grueling endurance races on the planet, the 24 Hours of Spa, the 24 Hours of Nürburgring, IMSA, and GT World Challenge Europe. He's also been living with type 1 diabetes since he was 11 years old. This episode gets into what it actually looks like to manage blood sugar in a fire suit, in a 130-degree cockpit, at 150 miles per hour, sometimes at 3 a.m. Tyler takes us back to his diagnosis in 2006 — an ICU stay, four IVs, and a very specific grief over the chocolate mousse at Epcot's France pavilion. From there, he walks us through the journey from go-karts in his dad's garage to GT3 race cars with 650 horsepower. Along the way, there was bullying in middle school over his diet, sneaking to the bathroom to give injections on dates, and a decision somewhere along the line to stop hiding his diabetes and start owning it. We get into the technical side, too: how OmniPod changed his race management strategy, why adrenaline sends his blood sugar climbing instead of crashing, what a 24-hour-race insulin plan actually looks like, and what it means to have a Gatorade button wired into your cockpit as an emergency low-blood-sugar protocol. Tyler also talks about the physical training side of racing — heart rate zone work, neck day (yes, neck day), and why a GT3 driver can be pressing 1,200 pounds of brake force per pedal. The episode wraps with something that's been sitting with both Rob and Tyler: the idea of trusting the process. For Tyler, the lesson comes through racing — you can't skip steps from spec Miata to GT3. For people with T1D, it's the same. Wherever you are in your management journey, that's where you are — and it's going to get better if you just keep going. Chapters: 00:00 Climbing out of a race car at 2 a.m. 00:51 Introducing Tyler Cook, GT3 driver with T1D 01:52 Diagnosis at 11: ICU, four IVs, and Epcot chocolate mousse 04:16 Go-karts at three, racing in the family DNA 06:20 Racing pre-CGM: going off vibes and feeling lows 07:29 Bullied for his diet in middle school 09:53 Dating with diabetes and deciding to stop hiding it 12:29 Going public: from fear of losing opportunities to advocacy 13:35 A potential cure and why staying healthy now matters 17:19 What GT3 racing actually is — and why you should go watch it 23:02 The Gatorade button: CGM and cockpit glucose management 24:28 130-degree cockpits, adrenaline spikes, and pre-race hydration 25:39 WHOOP strain scores: practice vs. race stint 28:37 Training for the car: heart rate zones, neck day, 1,200-lb brakes 36:45 What Tyler would tell 11-year-old himself: trust the process Resources: * Tyler Cooke Instagram * Breakthrough T1D * Conor Daly (T1D IndyCar driver Tyler mentioned)

Could hidden blood sugar problems be affecting energy, belly fat, sleep, and long-term health long before a doctor ever warns about them?Many men over 50 pay attention to cholesterol, blood pressure, and annual lab work. Far fewer understand what is happening with their blood sugar throughout the day or how it may be contributing to insulin resistance, weight gain, brain fog, and declining metabolic health.Karen Kennedy, author of the new book, Hack Your Blood Sugar, explains how a continuous glucose monitor can provide real-time feedback that helps men better understand how food, stress, sleep, and exercise affect their bodies. She also shares practical ways to use a CGM device without becoming obsessed with the numbers.What listeners will discover:Why a glucose monitoring device can reveal health patterns that traditional blood tests often missHow simple habits like meal timing and post-dinner walks can help lower blood sugarWhy stress and poor sleep may be driving blood sugar problems even when diet looks healthyListen for a practical framework that can help create more clarity, better decisions, and stronger health after 50.If you find this episode helpful, please subscribe and share it with friends and family.NEW FOR 2026: Click here to get my weekly Unstoppable After 50 Playbook

Send us Fan MailHello and welcome to CGM Presents: In the Word. My name is Dr. Stephanie Wright. On behalf of Charles George Missions, welcome to Season 14, “Spiritual Warfare.” This is episode 10 in our series, entitled “Spiritual Warfare Scriptures.” The resource for this series is the Word of God—the Bible—and the book “Spiritual Warfare Manual: ABC to PhD,” written by yours truly.Sit back, relax, and take a deep breath because today's spiritual warfare scripture is about rest. Matthew 11:28 says, “Come unto me, all ye that labor and are heavy laden, and I will give you rest.” Rest is a spiritual warfare weapon because spiritual warfare is perpetual—never-ending. When you commit your life to Christ, it is a lifetime commitment. There is no discharge from the Lord's army, so you will need to learn to rest in the Lord. Also remember, there is a great reward in serving Him— ETERNAL LIFE, and other bonuses we do not even know about are the compensation we receive. 1 Cor. 2:9 tells us we haven't seen nor heard, nor has our heart known the things God has prepared for us who love him.And consider this. The military soldier takes something called R&R (Rest and Relaxation). The spiritual warfare soldier has to do the same. It may not be a trip to a tropical island, although that would be nice. You may take an afternoon off and do what you please. But take a break and lighten up. Rest is good for your heart and soul. Prov. 17:22 tells us, A merry heart doeth good like a medicine: but a broken spirit drieth the bones.You need to refresh yourself for the next battle.My R&R includes sitting in a comfortable chair, viewing and listening to nature from my window during prayer time. The moment I sit down, I exhale, and I know I am at peace with God.So, take time every day, even if it's only 15 minutes, and rest in the Lord. Rest is another weapon in your spiritual warfare arsenal.Thank you for joining us today.Now, let's turn to Dr. Charles Wright, who will tell you how you may reach us and comment on this podcast.Until next time.If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham tackle one of the most fascinating and controversial questions in the diabetes world:What will happen first—a cure for Type 1 diabetes or a way to prevent it altogether?The conversation begins with a discussion around continuous glucose monitors, the barriers to bringing new diabetes technology to market, and why FDA approval plays such a significant role in innovation and accessibility.From there, Ken and Graham zoom out to examine diabetes on a global scale. They explore the challenges people with diabetes face in developing countries, the realities of insulin access, and whether advanced technology like CGMs should be prioritized when many people still struggle to obtain life-saving insulin.The discussion then shifts into the future of Type 1 diabetes research, including Teplizumab (Tzield), immunotherapy, stem cell research, autoimmune triggers, and the ongoing debate between prevention and cure.Along the way, Ken shares his perspective on the role that lifestyle factors—including stress, sleep, nutrition, exercise, and overall health—may play in autoimmune conditions, while Graham challenges the conversation by exploring whether vaccines, immunotherapy, or preventative treatments could eventually become the standard approach.This episode is an honest discussion about innovation, skepticism, hope, and the future of diabetes care.

We're back with Episode 59 and I am running on fumes. We processed four hogs this past weekend — start to finish, ourselves, no abattoir — and walked away with 600 lbs of high quality pork. 17-hour day. Worth every minute. If you eat meat, you owe it to yourself to understand where it comes from and be part of that process at least once. Circle of life, man.Greg and I also catch up on a full week into our new training split. Legs were brutal — 70,000 lbs of volume — and I'm still feeling it. We break down what's working, what we tweaked on chest day, and why I think this split might carry me all the way into prep for Worlds next November.Then we get into the Enhanced Games happening in Las Vegas. No drug testing, no banned substances — just whatever you want to pump into yourself. I get it, I understand why it exists, but it's a slippery slope. We also talk about the 23-year-old Brazilian bodybuilder who just passed away from hypoglycemia linked to exogenous insulin. It's a sobering reminder of where that road can lead.And to top it all off — I'm doing the sardine fast. Five days, 18 cans a day, iso-caloric at 3,000 calories. Got bloodwork done beforehand, CGM and continuous ketone monitor going, and we'll see what actually changes. Tune in next week for the full breakdown.Topics covered:Processing 4 hogs from start to finish on the homesteadCost breakdown: raising your own meat vs. buying retailOne week into the new high-volume training splitDEXA scan planning and comp prep timeline for WorldsThe Enhanced Games — human performance or chemistry contest?The dangers of exogenous insulin in bodybuildingThe sardine fast experiment beginsGreg Mahler is also a lifetime natural bodybuilder, and can be followed on Instagramhttps://www.instagram.com/ketogreg80/Register For My FREE Masterclass: https://www.ketobodybuilding.com/registration-2Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQ

In this episode, Tara breaks down the top five hidden blocks to better body composition—low deep sleep and under‑recovery, poor insulin sensitivity, not enough muscle, overeating "healthy" fats, and the "I come last" mindset—plus practical fixes you can start using right away.   RESOURCES: Learn more about Tara here: http://taragarrison.com Instagram: @coachtaragarrison @higher.coaching Get 10% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara   CHAPTERS: 00:00 – Solo intro: 5 biggest body comp blocks 00:45 – Sponsor: Peluva minimalist shoe ad 02:31 – Block #1: Under‑recovery and low deep sleep 07:00 – Fixing deep sleep: stress, nervous system, rituals 12:04 – Sleep environment: cool, dark, quiet room tweaks 13:31 – Night wakings, blood sugar drops, CGM insights 15:37 – Perimenopause, HRT and better sleep 21:40 – Block #2: Insulin resistance and labs that matter 27:33 – Fasting insulin ranges and getting more sensitive 34:23 – Block #3: Not enough muscle mass (why it matters) 41:31 – How to actually build more muscle and recover 41:57 – Block #4: "Eating healthy" but way too much fat 49:28 – Block #5: "I come last" mindset and boundaries 51:51 – Missing piece: fun, joy, play as real health    WORK WITH TARA: Are You Looking for Help on Your Wellness Journey? Here's how Tara can help you: TRY TARA'S APP FOR FREE: http://taragarrison.com/app INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv

Gillian discusses teenage rebellion, living with necrobiosis lipoidica, and a legal battle against medical school bureaucracy over a false-positive alcohol test caused by high blood sugar fermentation. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 ABLEnow save for today's needs or invest for tomorrow Tandem Mobi  Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. 

Send us Fan MailToday's spiritual warfare scripture comes from Isaiah 40:31.“But they that wait upon the Lord shall renew their strength, they shall mount up with wings as eagles, they shall run and not be weary, and they shall walk and not faint.”One of the most powerful weapons in our spiritual warfare arsenal is waiting on God. It is powerful because we do not realize what He is doing in the background for us while we are waiting. But when we are obedient to the Word of God, which tells us to “wait upon the Lord,” we honor Him, and because we honor Him by honoring His Word, He will do for us what Isaiah 40:31 says He will do.I speak based on a recent personal experience I alluded to in the last podcast. It took four years with a situation that was very painful, but in the end, in thecourse of my waiting and being obedient, praying, fasting, and listening to the Holy Spirit — in the end, God showed me all that he was doing in the background while I was waiting on Him to bring success so that I could mount up with wings as an eagle. God moved my enemies out of the way, exposed their lies, and empowered me, emotionally, financially, and most of allspiritually. He is now teaching me to run and not be weary as I fulfill the tasks that came with the victory. God gives us the victory, so that we can walk in it, and not be weary.Again, I waited upon the Lord during this four-year test by continuing in reading and studying His Word, praying with fasting, staying in church, giving financially and personally to the Lord's work—in short, I was obedient to the leading of the Holy Spirit. And, yes, I prayed for my enemies.While we are waiting on him, he will strengthen us, and when the test is finally over, we will see what he has been doing in the background. If you don't see it in this life, maybe He will reveal it to you in the next life—but truthfully, I don't think you will care when you get to heaven.So, wait on the Lord for He shall renew your strength, and you shall mount up with wings as an eagle, you shall run and not be weary, and you shall walk and not faint.If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Dr. Corey Schuler, PhD(c), FNP, DC, CNS, and director of medical affairs at Allergy Research Group, details his paper “Energy Allocation Resilience and Endocrine Integration” in the International Journal of Molecular Sciences. He introduces the Energy Allocation System (EAS), which emphasizes how the body allocates energy—not just produces it—and links many symptoms to impaired bioenergetics and resilience. They discuss mitochondria as energy generators and cellular signaling hubs, the integrated stress response and endocrine coordination (HPA axis, thyroid, gonads), and mitohormesis/eustress (exercise, fasting, heat/cold, circadian “zeitgebers”). Schuler explains nuanced testing for fatigue (diurnal cortisol, CGM patterns, thyroid markers including T3/reverse T3) and a case of a perimenopausal woman where oral contraceptives and cortisol dysregulation affected glucose patterns. They cover mitochondrial support (removing obstacles like pollutants/antibiotics, triglycerides, carnitine, dietary fats, micronutrients) and pacing/sequencing lifestyle interventions.

In this episode, Meg Bomley shares her T1D journey from being diagnosed at 18 years old and spending eight years on MDI without a CGM, to becoming someone who feels deeply empowered in her body and her diabetes.Meg first came on the podcast in 2022 after graduating from Risely coaching. At the time, she had just come out of a season of constant lows, burnout, and feeling completely overwhelmed after switching to a pump without the support she needed.Today, she's back as a nationally board certified health coach, and 35 weeks pregnant with type 1 diabetes, one of Risely's top coaches.The majority of this conversation is the reality of navigating pregnancy with T1D: the nausea, insulin resistance, fear of highs, changing carb ratios, and learning to trust yourself in this season.WHAT WE COVER:Why Meg resisted pumps and CGMs for nearly 8 years after diagnosisThe “biggest disaster ever” that happened when she first switched to a pumpWhat finally helped her stop feeling resistant, overwhelmed, and burnt out with diabetesHow coaching helped her uncover mindset blocks that had nothing to do with insulin or carb countingThe first sign Meg noticed that told her her insulin resistance was changing after getting pregnantHow she managed nausea, vomiting, insulin on board, and eating mostly carbs during pregnancyThe difference between taking 5 units for oatmeal pre-pregnancy vs. 16 units during pregnancyWhat it's actually like mentally to watch yourself take “large amounts of insulin” every dayWHAT'S NEXT:

In this episode of the Your Diabetes Insider Podcast, I'm breaking down how I personally handle Memorial Day BBQs and cookouts without my blood sugars going completely off the rails. From grazing on appetizers, hidden carbs in "simple" foods, and delayed fat spikes, to figuring out insulin timing, pre-bolusing, and using activity to boost insulin sensitivity before you even show up - this is everything I wish I knew earlier. If BBQs usually turn into a CGM stress-fest for you, this will help you feel more prepared so you can actually enjoy the food, the people, and the day without constantly worrying about your blood sugar! Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching   RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff LET'S TALK! Instagram: @yourdiabetesinsider Tiktok: @yourdiabetesinsider

Send us Fan MailHello and welcome to CGM Presents: In the Word. My name is Dr. Stephanie Wright. On behalf of Charles George Missions, welcome to Season 14, “Spiritual Warfare.” This is episode 8, and we are starting a new series, “Spiritual Warfare Scriptures.” The resource for this series is the book “Spiritual Warfare Manual: ABC to PhD,” written by yours truly.We will focus on one scripture each time we meet, and these will be vignettes or very short presentations. Use these scriptures to build up your arsenal for spiritual warfare by memorizing, meditating and implementing them into your daily walk with the Lord.Today's scripture is from Isaiah 54:17, No weapon that is formed against YOU shall prosper; and every tongue that shall rise against YOU in judgment YOU shall condemn. This is the heritage of the servants of the Lord, and their righteousness is of me, saith the Lord.Why is this such a popular scripture? I believe it's popular because it represents victory in whatever turmoil, task, or terror that the enemy tries to attack you with. No weapon means “no weapon,” but it does not mean a weapon won't be formed; it means the weapon will not prevail against you.No weapon formed against you will meet its intended end. So, if someone is trying to destroy you, physically, mentally, financially—they are not going to succeed because God will step aside and let the enemy turn on them, and they in turn will start fighting against each other. I have experienced this firsthand. God stepped aside and allowed the enemy to attack my enemies, and then those same enemies started turning on each other.Let's look at the second half of Isaiah 54:17. People often overlook the second half of this verse, and every tongue that shall rise against YOU in judgment YOU shall condemn. This is the heritage of the servants of the Lord and their righteousness is of me, saith the Lord.This tells us that the words people speak are weapons but again, their word weapons will not prevail against you. But what does this scripture tell us to do when words are spoken against us in judgment? It is our right—our heritage because Jesus gave us that right through His victory on the Cross—our responsibility to speak against those things and speak good things into our lives. This is why we need to know the Word of God. This is why we need scriptures in our arsenal so we can wage spiritual warfare against Satan and his demonic forces. This is why in this series, we are studying scriptures on spiritual warfare to prepare you   formed against you shall prosper.”Thank you for joining us today. We look forward to sharing another scripture on spiritual warfare next time.Now, let's turn to Dr. Charles, who will tell you how you may reach us and comment on this podcast. If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

It's In The News, where we bring you the top diabetes stories and headlines happening now. Top stories this week: Dexcom shares details of its next generation CGM, T1D and GLP-1 studies, weight loss management on GLP-1 medications updates, all-in-one CGM and pump, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: XX Dexcom announces some features of it's next generation CGM – the G8. We've been talking about this with CEO Jake Leach for a while now – it will be a 50% smaller with what they're calling advanced sensing capabilities. According to Leach, G8 will adapt to the physiologic variability of each user. It has additional technology built in, based on a new silicon chip design and algorithm. 15 day wear is now the baseline for all Dexcom sensors moving forward. At launch the G8 will only measure glucose but the plan is for a multi-analyte version to follow. That would measure ketones and potassium. Ketones we know – but potassium is very important for people with kidney and possible for people taking some diabetes meds. It's an interesting space to watch.. btw, analyte is just a medical word for the specific thing you're measuring – the target of the test you're running. we're going to hear that word a lot I think..   Looks like an FDA submission for the G8 next year.. with an outside the US launch the following year. https://www.drugdeliverybusiness.com/dexcom-unveils-next-gen-g8-cgm/ XX Glucotrack has submitted its implantable continuous blood glucose monitor (CBGM) for FDA IDE, that's investigational device exemption and would enable the company to initiate a U.S. clinical study for the fully implantable technology. Rutherford, New Jersey-based Glucotrack's device features no on-body external component. The company aims to offer it for three years of continuous, accurate blood glucose monitoring for a more convenient, less intrusive solution. Unlike traditional CGMs that measure glucose in interstitial fluid, the CBGM measures glucose levels directly from the blood. The implant goes five centimeters within the subclavian vein. Glucotrack's active implantable device has a small battery and some electronics that go just under the skin in the pectoral region. The location of the implant is not in a major vessel, but the implant can measure real-time glucose levels as pulsatile blood flows over the tip of the sensor. https://www.drugdeliverybusiness.com/glucotrack-submits-long-term-implantable-cbgm-fda-ide/ XX PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. However, this system would be one device that features both the pump and CGM technology.   PharmaSens and SiBionics also have a collaboration aimed at developing the all-in-one solution. They are jointly developing the next-generation Niia insulin patch pump with a SiBionics CGM. PharmaSens expects a second feasibility study in the second quarter to evaluate the next-generation pump with SiBionics' CGM.   PharmaSens says the clinical feasibility study of Niia demonstrated for the first time ever that the combined offering is, in fact, feasible. It believes its device addresses the need for alternatives to multi-device diabetes management. systems.   Aggregated MARD for the investigational device came in at 11.6%. A MARD target of less than 10% is considered ideal for CGM devices, but PharmaSens said that, in the context of the early feasibility study, the results were encouraging and provide evidence supporting the development of an all-in-one system. https://www.drugdeliverybusiness.com/pharmasens-efs-insulin-patch-pump-cgm/ XX   XX ViCentra launches the newest version of the Kaleido pump system in Europe. This is that small colorful pump, with Diabeloops algorithm and the Dexcom G7. It'll be in Germany and the Netherlands later this summer. https://hellokaleido.com/vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system/--   XX Diabeloop just got CE Mark approval for DBLG2 integrations – it's latest AID platform the company has kicked off the gradual European launch of the technology. It currently offers DBLG2 as a smartphone application on Android, with iOS integration coming soon. As you just heard, it's integrated with kaleido and the company says it plans to make additional configuration for DBLG2 with alternative pumps "available soon." Running on a user's smartphone, DBLG2 works as a self-learning algorithm. It continuously analyzes glucose data, calculates insulin needs in real time and automatically adjusts delivery. https://www.drugdeliverybusiness.com/diabeloop-fda-next-gen-algorithm-g7/   XX Among adults with type 1 diabetes (T1D), the initiation of GLP-1-based therapy was associated with a lower risk for all-cause death, several cardiovascular outcomes, all-cause hospitalisations, and hypoglycaemia, without a higher risk for diabetic ketoacidosis.   METHODOLOGY: Researchers in Greece conducted a retrospective cohort study utilising real-world data from a global health research network to evaluate the association between GLP-1-based therapy and cardiovascular and renal outcomes in adults with T1D. A total of 4088 patients receiving GLP-1-based therapies (median age, 43 years; 34.3% men) were propensity score matched with an equal number of patients not receiving the treatment. The risk for hypoglycaemia was lower with GLP-1-based therapy (hazard ratio, 0.72; P = .021); however, the risk for diabetic ketoacidosis did not differ significantly between the two groups. https://www.medscape.com/viewarticle/glp-1-drugs-tied-cardiovascular-benefits-t1d-2026a1000fbx   XX Eli Lilly and Company (NYSE: LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after switching from higher doses of injectable incretin therapy. The findings from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN, were presented at the 33rd European Congress on Obesity (ECO) and published in The Lancet and Nature Medicine, respectively.   "Weight regain remains one of the biggest challenges in obesity care, and is often the result of treatment interruptions that cause biology to work against patients, undoing the progress they've made," said Louis J. Aronne, M.D., FACP, DABOM, founder and Chair Emeritus of the American Board of Obesity Medicine, former president of The Obesity Society, Fellow of the American College of Physicians, world-renowned obesity specialist and Lilly consultant. "These medicines can be used for long-term maintenance today, and results from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN provide additional evidence of their potential when switching from higher doses of injectable incretin therapy." https://investor.lilly.com/news-releases/news-release-details/lillys-foundayo-and-lower-dose-zepbound-helped-people-maintain XX Scientists in Sweden have developed a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice. When transplanted into diabetic mice, the cells gradually restored the animals' ability to regulate blood sugar. Long way to go, as we say with most of these mice studies. https://www.sciencedaily.com/releases/2026/05/260505234620.htm XX Interesting look at how the body controls sugar storage – apparently this finding challenges long-standing biology concepts and could open new directions for disease treatment. Published in Nature, the study describes a potential method for directly reducing glycogen, the stored form of sugar in the body. These scientists discovered that glycogen can be directly regulated by ubiquitin, a protein best known for marking damaged proteins for recycling or removal. The study is the first to show that ubiquitin can regulate glycogen in humans, overturning more than 50 years of scientific understanding. Excess glycogen is also associated with more common health problems, including diabetes, obesity, liver disease, and heart disease.       https://scitechdaily.com/scientists-just-rewrote-biology-hidden-mechanism-could-transform-diabetes-treatment/ XX A new Oklahoma law will give parents the option to have their children screened for Type 1 Diabetes.   The measure passed with overwhelming bipartisan support in the Legislature and takes effect Nov 1. Oklahoma consistently ranks among the states with the highest rates of diabetes and diabetes-related deaths. The law gives parents access to antibody testing that can detect risk years before symptoms develop, helping families take preventive action and avoid emergency room visits. https://journalrecord.com/2026/05/11/oklahoma-law-expands-access-type-1-diabetes-screening/ XX More to come including a new study trying to figure out why some people are more likely to develop diabetes, a look at cannabis and preventing metabolic disorders, and XX   A National Institutes of Health (NIH)-funded study has identified key differences in human pancreatic islet cells that may help explain why some people are more likely to develop diabetes. Researchers found that the mix of hormone-producing cells in the pancreas varies widely from person to person, and that variation plays a central role in how the body regulates blood sugar. The study involved a deep dive into islet cell function that is linked to donor traits associated with observable characteristics, or phenotype, such as sex, race and ethnicity, as well as genetic information, or genotype, including predicted ancestry and genetic risk for both type 1 and type 2 diabetes. The findings highlight that islet cell composition, rather than the physical size and shape of islets, is a key factor in regulating hormone release. The team found that the makeup of pancreatic islets plays a major role in how effectively they release insulin and glucagon — key hormones that regulate blood glucose. Islets with a higher proportion of insulin-producing beta cells showed stronger insulin secretion in response to various stimuli, while higher levels of alpha and delta cells were generally linked to reduced insulin output. In addition, the researchers found that islet hormone secretion is affected by donor traits, such as sex, race and ethnicity and their genetic makeup, including ancestry predicted from genetic testing and genetic risk for type 2 diabetes. Combined, the findings of the study have significant implications for understanding the factors that may predispose people to diabetes. "This study is the tip of the iceberg," said Dr. Evans-Molina. "We hope this dataset becomes useful to the entire diabetes research community and that researchers use it to answer questions about the genotype-phenotype correlation within these data."   https://www.nih.gov/news-events/news-releases/nih-funded-study-maps-human-pancreatic-islet-cells-offering-new-clues-diabetes-risk XX XX XX Research published recently in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.   "This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer – whether this is related to weight control, improve cardiovascular health or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Ph.D., MPH, associate director for population sciences and the Gordon D. Ginder, M.D., Chair in Cancer Research at VCU Massey Comprehensive Cancer Center.   Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival.   What are GLP-1 drugs? Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Approved to treat type 2 diabetes in 2005 and weight management in 2021. Impacts on breast cancer survival and recurrence are still unclear. Since 2020, the use of these drugs has increased dramatically, where approximately 12% of Americans have used GLP-1s for weight loss, according to a RAND report.   The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes.   GLP-1 RA use was associated with an overall lower risk of death from any cause over a 10-year follow-up period among breast cancer patients. Additionally, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment.   "Our findings align with emerging preclinical research and contribute to a growing body of literature related to GLP-1 RA use in oncology settings," said study lead author Kristina L. Tatum, PsyD, MS, of the VCU School of Public Health.   What's next? Further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes. The research team intends to further evaluate these correlations through randomized clinical trials.   "Our study underscores the potential of GLP-1 RAs as an adjunct strategy for improving cancer-related outcomes among patients with breast cancer, although clinical trials are needed to inform effective therapeutic approaches and clinical decision making," Fuemmeler said. https://www.oncology-central.com/could-glp-1-receptor-agonists-improve-outcomes-for-breast-cancer-patients-with-obesity-or-with-type-2-diabetes/ XX Researchers at UC Riverside gave cannabis to obese mice and found that not only did the rodents lose weight, but when given a concentrated cannabis oil, the mice also saw striking benefits in their metabolic function. DiPatrizio said his team studied the issue to better understand why cannabis users show significant reductions in weight and risk for diabetes compared with nonusers. "We would think that chronic cannabis users would be eating more and weigh more, but it's just the opposite," DiPatrizio said. Scientists are increasingly examining the possibility that cannabis compounds could fight obesity or metabolic disorders like diabetes. Cannabinoids interact with the body's endocannabinoid system, which partially controls nearly every aspect of our physiology, including metabolism and appetite. That creates the possibility that targeting this widespread system could unlock new therapies for these conditions. https://www.sfgate.com/cannabis/article/cannabis-weight-loss-california-study-22255328.php XX A new campaign launched by diaTribe and Genentech aims to empower and educate people about diabetes-related eye disease. Here's what you can do today to protect your eye health. To help address these barriers, diaTribe and Genentech partnered to launch All Eyes on DME, a new campaign that aims to spread awareness and educate people at-risk for or living with diabetes-related eye conditions like DME. Also partnering in the campaign is actor and comedian Damon Wayans, who wanted to share his journey (and, of course, a joke or two) with type 2 diabetes to open up the conversation about what is often a stigmatized or less talked about topic: eye health and diabetes.   One of these important conversations happened recently at the All Eyes on DME launch in New York City, where Wayans joined a panel of experts, advocates, and people living with DME to talk about diabetes-related eye disease and how to help prevent it. https://www.alleyesondme.com/dme-in-the-spotlight.html https://diatribe.org/diabetes-complications/all-eyes-dme-new-campaign-spotlights-eye-health-and-diabetes

Rafael Pepen was diagnosed with Type 1 diabetes at 17, right in the middle of rehearsing for his very first musical in the Dominican Republic. Without access to a CGM or carb counting education, he learned to manage largely on instinct. Years later, he moved to the US, pursued his dream of performing professionally, and eventually landed at Disney, where he now performs five high cardio shows a day.In this episode, Rafael sits down with Lauren to talk about what it actually looks like to manage T1D in a life that never slows down. He shares the months of burnout, panic attacks around lows, and constant roller coaster blood sugars that led him to seek coaching, and what shifted on the other side of that.WHAT WE COVER:What it was like to be diagnosed at 17 in the Dominican Republic with limited access to education, CGMs, or carb counting guidanceThe unique challenge of managing T1D across five high cardio shows a day and why it is a completely different beast from a traditional performance scheduleThe moment things started to unravel at Disney and what five months of daily lows, panic attacks, and burnout actually felt like from the insideWhat shifted when Rafael started working with a Risely coach and the tools that made the biggest difference for his day to day managementThe emotional side of T1D that most people never talk about, including what it felt like to cry during a low and the moment that started to changeWhat Rafael is still working toward and the one thing he wants most from his relationship with diabetes going forwardWHAT'S NEXT:

Click to Send us a text!We challenge the idea that constant snacking boosts metabolism and explain how all-day grazing can keep insulin elevated and slowly erode energy, focus, and recovery in motorsports. We translate insulin resistance into real race-day consequences and lay out a clearer plan for meal rhythm, testing, and metabolic flexibility. • why “always fed” habits can create subtle crashes and brain fog • what insulin does and how chronic elevation leads to insulin resistance • common race weekend fueling patterns that keep glucose spiking • why context matters for athletes and why fasting is not for everyone • performance costs in motorsports like slower decisions and slower recovery • early detection with hemoglobin A1C and advanced at-home testing • using a CGM to see food, stress, sleep, and travel effects in real time • practical anchors like the 30/ 10/ 3 rule, strength training, sleep, and stress reduction • post-meal movement to rebalance blood sugar fast be sure to click that subscribe button so you never miss an episode. If you're serious about optimizing performance at the root level, you can apply to work with Victory Lane Wellness at victorylanewellness.com Support the showAs a token of gratitude, of course you're interested in these FREE and powerful resources, and because you enjoy the show, first be sure to leave your 5-STAR Review HERE!

What if your body could warn you before a relapse happens? In this fascinating episode, Dr. Vera Tarman sits down with Bob Messerschmidt — biomedical engineer, inventor, and one of the architects behind the original Apple Watch's health-sensing technology — to explore a surprisingly simple but powerful biomarker: the erythrocyte sedimentation rate (ESR). Bob is the founder of Core Health and has developed an FDA-registered at-home device that tracks chronic low-grade inflammation over time. For those of us in the food addiction and recovery world, this conversation opens a compelling new door: could inflammation tracking be the missing feedback loop for people working to stay abstinent from ultra-processed foods?

Scott and Jenny talk about how to bolus 4 ultra processed food.  Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 ABLEnow save for today's needs or invest for tomorrow Tandem Mobi  Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 20% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it.